Acadian Asset Management LLC Harrow Health, Inc. Transaction History

Acadian Asset Management LLC

$32.2 Billion
Q3 2024

A detailed history of Acadian Asset Management LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 4,148 shares of HROW stock, worth $177,783. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,148

Holding current value

$177,783

% of portfolio

0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$20.85 - $46.47 $86,485 - $192,757	4,148 New	4,148 $186,000
Q1 2023 May 11, 2023	SELL	$13.84 - $21.46 $1.98 Million - $3.07 Million	-143,162 Reduced 27.92%	369,662 $7.82 Million
Q4 2022 Feb 14, 2023	SELL	$10.28 - $14.78 $324,961 - $467,210	-31,611 Reduced 5.81%	512,824 $7.57 Million
Q3 2022 Nov 14, 2022	SELL	$6.57 - $24.88 $40,865 - $154,753	-6,220 Reduced 1.13%	544,435 $6.57 Million
Q2 2022 Aug 09, 2022	BUY	$5.75 - $7.74 $102,068 - $137,392	17,751 Added 3.33%	550,655 $4.01 Million
Q1 2022 May 12, 2022	SELL	$6.77 - $8.66 $31,385 - $40,147	-4,636 Reduced 0.86%	532,904 $3.63 Million
Q4 2021 Feb 10, 2022	BUY	$8.5 - $12.0 $119,450 - $168,636	14,053 Added 2.68%	537,540 $4.64 Million
Q3 2021 Nov 12, 2021	BUY	$6.99 - $10.6 $305,008 - $462,531	43,635 Added 9.09%	523,487 $4.76 Million
Q2 2021 Aug 11, 2021	BUY	$6.68 - $11.07 $383,472 - $635,484	57,406 Added 13.59%	479,852 $4.46 Million
Q1 2021 May 11, 2021	BUY	$6.26 - $11.03 $187,036 - $329,554	29,878 Added 7.61%	422,446 $2.85 Million
Q4 2020 Feb 11, 2021	BUY	$4.76 - $6.93 $112,878 - $164,338	23,714 Added 6.43%	392,568 $2.69 Million
Q3 2020 Nov 09, 2020	SELL	$4.71 - $7.36 $1.16 Million - $1.81 Million	-246,220 Reduced 40.03%	368,854 $2.06 Million
Q2 2020 Aug 12, 2020	SELL	$3.61 - $6.47 $21,789 - $39,052	-6,036 Reduced 0.97%	615,074 $3.2 Million
Q1 2020 May 11, 2020	SELL	$3.5 - $7.31 $70,388 - $147,011	-20,111 Reduced 3.14%	621,110 $2.37 Million
Q4 2019 Feb 06, 2020	BUY	$4.6 - $7.88 $133,878 - $229,339	29,104 Added 4.75%	641,221 $4.99 Million
Q3 2019 Nov 07, 2019	BUY	$4.89 - $8.0 $251,932 - $412,160	51,520 Added 9.19%	612,117 $3.44 Million
Q2 2019 Aug 08, 2019	BUY	$4.2 - $8.7 $682,327 - $1.41 Million	162,459 Added 40.8%	560,597 $4.88 Million
Q1 2019 May 09, 2019	BUY	$4.75 - $7.1 $1.89 Million - $2.83 Million	398,138 New	398,138 $1.98 Million

Others Institutions Holding HROW

# of Institutions

174

Shares Held

21.3M

Call Options Held

792K

Put Options Held

619K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $1.16B
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account

Acadian Asset Management LLC Harrow Health, Inc. Transaction History